IMCIVREE 10 mg/ml, solution for injection bottle, 1 ml
Active ingredients: Setmelanotide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IMCIVREE 10 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- flacon(s) multidose(s) en verre de 1 ml
- Marketing authorisation holder
- RHYTHM PHARMACEUTICALS NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Feb 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69966525CIP73023656CIP133400930236567Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SETMÉLANOTIDEsolution | 10 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.